Brief: Cyclopharm Says U.S. FDA Formally Acknowledged Receipt Of Co's 30 March 2023 Reply

Cyclopharm

24/04/2023 02:43

April 24 (Reuters) - Cyclopharm Ltd  CYC.AX :
    * U.S. FDA FORMALLY ACKNOWLEDGED RECEIPT OF CO'S 30 MARCH
2023
REPLY TO USFDA'S COMPLETE RESPONSE LETTER
    * REMAINS CONFIDENT OF COMMENCEMENT OF COMMERCIAL SALES OF
TECHNEGAS IN U.S. SHORTLY AFTER GOAL DATE IN LATE 2023

Source text for Eikon:  ID:nASX86fs9q 
Further company coverage:  CYC.AX 

 ((Reuters.Briefs@thomsonreuters.com;))